e8vk
Table of Contents

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
Pursuant To Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) November 17, 2008
PSYCHEMEDICS CORPORATION
(Exact Name of Registrant As Specified In Its Charter)
Delaware
(State or Other Jurisdiction of Incorporation)
     
1-13738
(Commission File Number)
  58-1701987
(I.R.S. Employer Identification No.)
     
125 Nagog Park, Acton, Massachusetts
(Address of Principal Executive Offices)
  01720
(Zip Code)
(978) 206-8220
(Registrant’s Telephone Number, Including Area Code)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o   Pre-commencement communications pursuant to Rule 13e4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 


TABLE OF CONTENTS

ITEM 8.01     OTHER EVENTS
ITEM 9.01     FINANCIAL STATEMENTS AND EXHIBITS.
SIGNATURE
EXHIBIT INDEX
Ex-99.1 Press Release dated November 17, 2008


Table of Contents

ITEM 8.01     OTHER EVENTS
     On November 17, 2008, Psychemedics Corporation issued a press release announcing the declaration of a special cash dividend payable on December 24, 2008 to holders of record on December 10, 2008. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated by reference herein.
     Limitation on Incorporation by Reference. The information in this Form 8-K and the Exhibit attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, regardless of any general incorporation language in such filing.
     Cautionary Note Regarding Forward-Looking Statements. Except for historical information contained in the press release attached as an exhibit hereto, the press release contains forward-looking statements which involve certain risks and uncertainties that could cause actual results to differ materially from those expressed or implied by these statements. Please refer to the cautionary note in the press release regarding these forward-looking statements.
ITEM 9.01     FINANCIAL STATEMENTS AND EXHIBITS.
     
 
   
 
  (d)     Exhibits
 
   
 
  The following exhibits are filed herewith:
 
   
 
  99.1     Press Release dated November 17, 2008.

2


Table of Contents

SIGNATURE
     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
         
  PSYCHEMEDICS CORPORATION  
 
Dated: November 19, 2008    
 
  By:   /s/ Raymond J. Ruddy    
    Raymond J. Ruddy   
    Vice President and Controller   

3


Table of Contents

         
EXHIBIT INDEX
       
Exhibit    
Number   Description
 
   
99.1
  Press release dated November 17, 2008 of Psychemedics Corporation announcing the declaration of a special cash dividend.